News | Breast Density | February 08, 2019

New Mexico Enacts Breast Density Inform Law

Becomes 36th state to require some level of patient notification

breast density cancer awareness

Governor Michelle Lujan Grisham has signed breast density inform bill, HB66 into law, making New Mexico the 36th state to require communication about breast density to women after their mammogram.  The law goes into effect July 1, 2019. State bills have also been introduced in Georgia and South Dakota this session.

New Mexico Representative Elizabeth “Liz” Thomson, a breast cancer survivor, was instrumental in introducing and advocating passage of this bill. Governor Grisham’s signature on the bill means that nearly 89% of American women now live in states that require women be provided some level of notification about breast density.

Approximately 40% of women aged 40 and over have dense breast tissue that may hide cancers on mammography.  Women with dense breasts may benefit from supplemental screening tests, in addition to mammography, to detect cancers. Women with extremely dense breasts are 4-6 times more likely to develop breast cancer than women with the least dense breasts. Providing women with their breast density classification would enable them to initiate discussions with their physicians about whether  supplemental screening might be beneficial.

While the New Mexico law mandates that women be notified of their individual breast density classification, state laws vary in depth and breadth of notification. Not all “inform” laws actually provide women with information about their own breast density; some only provide general information about breast density. There is a growing call for a single national reporting standard to address this disparity. On the federal regulatory level, the Food and Drug Administration anticipates publishing proposed amendments to the Mammography Quality Standards Act (MQSA) regulations for notice or comment.  On the federal legislative front, the Breast Density and Mammography Reporting Act of 2017 was introduced in both the Senate (S 2006) and House (HR 4122).

For further explanation about federal efforts and for state-by-state legislative analysis, visit the “Legislative Information” tab at educational website DenseBreast-info.org.

Related Content

Right mediolateral oblique (MLO) mammograms for different women with the same breast thickness but varying breast density.

Right mediolateral oblique (MLO) mammograms for different women with the same breast thickness but varying breast density.

News | Breast Imaging | July 30, 2021
July 30, 2021 — Volpara Health, a global health technology software leader providing an integrated breast care platfo
Volpara Health, a global health technology software leader providing an integrated breast care platform for the delivery of personalized breast care, has signed an agreement with Invitae Corporation, a leader in medical genetics, to bring Invitae's genetic testing services to Volpara's customers in the United States. 
News | Breast Imaging | July 29, 2021
July 29, 2021 — Volpara Health, a global health technology software leader providing an...
Registration is now open for the Radiological Society of North America (RSNA) 107th Scientific Assembly and Annual Meeting, the world’s largest annual radiology forum, to be held at McCormick Place Chicago, Nov. 28 – Dec. 2, 2021

Getty Images

News | RSNA | July 21, 2021
July 21, 2021 — Registration is now open for the Radiological Society of North America (...
According to ARRS’ American Journal of Roentgenology (AJR), return to routine screening for BI-RADS 3 lesions on supplemental automated whole-breast US (ABUS) substantially reduces the recall rate, while being unlikely to result in adverse outcome

Normal right mediolateral oblique (A) and craniocarudal (B) view screening mammograms demonstrate density C breasts. Coronal (C), transverse (D), and reconstructed lateral (E) views from supplemental automatic breast ultrasound (ABUS) demonstrates 7 mm circumscribed slightly hypoechoic circumscribed lesion at 11 o’clock position in right breast. Lesion was classified as BI-RADS 3. Patient has undergone yearly mammograms for 4 years following the ABUS examination with no breast cancer diagnosis.

News | Breast Imaging | July 16, 2021
July 16, 2021 —...
Volpara now holds 98 granted patents across 27 countries
News | Breast Imaging | July 16, 2021
July 16, 2021 — Volpara has recently been granted another patent by the...
Interviews with the 1,000 at-risk patients also led to some interesting conclusions, Fine said. Even in the early days of 3D mammography, most women interviewed had at least heard about the technology.

Getty Images

News | Mammography | July 15, 2021
July 15, 2021 —  For any type of diagnostic test, technology that helps improve the reliability of test results is a
ujifilm's robust medical systems portfolio includes a comprehensive product lineup covering CT, MRI, fluoroscopy, digital radiography, women’s health, ultrasound, systems integration, endoscopy and endosurgery, enterprise imaging, assisted reproductive technology, cell culture media, cell therapy development, In-Vitro diagnostics (IVD), and investigational drug development
News | Radiology Imaging | July 14, 2021
July 14, 2021 — Fujifilm announced the launch of the ...
A new study set out to learn more about breast health for Black women and to establish a better understanding of the breast screening landscape by analyzing mammograms, screening intervals and interpretation performance for Asian, Black and white women across health systems throughout the United States, with participation from Advocate Health Care, Sanford Health and the University of Pennsylvania Health System.

Getty Images

Feature | Breast Imaging | July 06, 2021 | By Linda Goler Blount, MPH
Due to dangerous implications for years to come, facilities must increase efficiency and capacity for breast cancer care to recover from the impact of COVID-19

Getty Images

Feature | Breast Imaging | July 06, 2021 | By Ananth Ravi, Ph.D.
The challenges